SYT yields 0.27% · PFE yields 6.13%● Live data
📍 SYT pulled ahead of the other in Year 1
Combined, SYT + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SYT + PFE for your $10,000?
SYLA Technologies Co., Ltd., through its subsidiaries, primarily develops, constructs, sells, and manages apartments in Japan. It also engages in the land purchase, design, construction, operation, and maintenance of solar power plants. In addition, it offers real estate leasing, brokerage, and management services; and real estate crowdfunding service on the Rimawari-kun platform. Further, the company designs, develops, manufactures, and sells computers for artificial intelligence (AI) and graphics processing, as well as offers computer maintenance and management services; Rimawari-kun AI, a system that automatically collects various real estate data found online and compiles indexes; real estate investment, machine learning algorithms, robotic process automation, and business systems using the system. Additionally, it provides consulting on business automation and AI system implementation for corporations; offers consulting on real estate investment and asset management; operates and sells renewable energy data centers; and sells and maintains solar and biomass power generation equipment. The company also engages in electricity brokerage, renewable energy trading, and trade brokerage activities. The company was formerly known as SYLA Holdings Co., Ltd. SYLA Technologies Co., Ltd. was incorporated in 2009 and is headquartered in Tokyo, Japan.
Full SYT Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.